Eye and brow asymmetry is incredibly common, and it’s something I see frequently in practice. In most cases, this type of asymmetry develops gradually over time rather than being present from childhood. Contributing factors can include natural facial dominance, differences in muscle strength, aging-related volume loss, skin laxity, and even how we smile or use our facial muscles day to day. The good news is that many cases like the one you’re describing can be improved non-surgically using a multi-modality approach. Rather than relying on a single treatment, we look at the face holistically and address each contributing factor thoughtfully and conservatively. Depending on what’s driving the asymmetry, options may include: Upneeq, an FDA cleared, simple daily eyedrop that helps open up the eyes by lifting the muscle of the eyelid, addressing asymmetry.Neuromodulators to rebalance muscle pull around the brows and eyes, which can help improve eyelid opening and brow positionStrategic dermal filler placement to restore subtle volume and structural support where asymmetry has developedSkin-tightening or collagen-stimulating treatments to improve tissue support over timeCustomized treatment planning that accounts for facial movement, expression, and how the face changes when smiling (which is often when asymmetry becomes more noticeable) Photos can be helpful, but nothing replaces an in-person evaluation. A thorough assessment allows us to determine whether the asymmetry is primarily muscular, structural, or volume-related, and that distinction is key to choosing the safest and most effective plan. The goal is never to make the face perfectly symmetrical (which isn’t natural), but to create better balance while preserving your unique features. Aesthetic treatments should always be discussed with and performed by a trained, licensed, and medically certified aesthetic provider. The recommendations above are for educational purposes only and do not replace an in-person consultation, examination, or personalized medical advice.